Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-02-06 @ 5:09 AM
Study NCT ID:
NCT02857920
Status:
COMPLETED
Last Update Posted:
2020-09-14
First Post:
2016-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Sponsor:
Fuda Cancer Hospital, Guangzhou
Organization: